Atlas Trials

An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo

Clinical trial NCT02763761 · WITHDRAWN

Trial details

NCT number
NCT02763761
Sponsor
Bristol-Myers Squibb
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Cell CarcinomaMelanomaLung Cancer
Start date
2016-08-16
Primary completion
2017-03-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.